Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

NCT00299221 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Immunosuppression

Interventions

DRUG: Tacrolimus
DRUG: combination therapy

Sponsor

Newark Beth Israel Medical Center

Collaborators

[object Object]